Comparative Efficacy, Safety and Tolerability of Olopatadine Extended Release Tablets and Olopatadine Immediate Release Tablets in the Treatment of Seasonal Allergic Rhinitis - A Randomized, Double-Blind Study.
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Olopatadine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Registrational; Therapeutic Use
- Sponsors Ranbaxy Laboratories
- 01 Mar 2013 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
- 24 Dec 2010 Planned initiation date changed from Nov 2010 to Jan 2011 Clinical Trials Registry - India.
- 15 Sep 2010 Planned initiation date changed from 1 Aug 2010 to 1 Nov 2010 as reported by Clinical Trials Registry - India record.